USFDA inspects Alembic Pharma’s facility in Karkhadi
The US health regulator issued a form 483 with two observations
Author
Wockhardt gets DCGI approval for two new antibiotics
EMROK (IV) and EMROK-O (Oral) have got approval for acute bacterial skin and skin structure infections including diabetic foot…
NCB busts psychotropic medicines racket seizes over 7 lakh tablets, injections
A total of 7,24,840 tablets and capsules, 1,400 injections and 80 CBCS (codeine-based cough syrup) bottles have been seized, an…
Strides arm receives EIR for its US facility
Strides Pharma Inc received EIR from the United States Food and Drug Administration (USFDA) for the inspection conducted at its…
Cipla announces closure of USFDA inspection at Patalganga facility
Following the inspection by USFDA in November last year, the company has received the Establishment Inspection Report (EIR),…
Govt may impose anti-dumping duty on pharma chemical from China, Saudi Arabia
Countries carry out anti-dumping probe to determine whether their domestic industries have been hurt because of a surge in cheap…
Delay in notification of e-pharmacy draft rules causing concern in the sector: FICCI
There is no violation of any existing act and rules in current e-pharmacy model. However, there are certain difficulties that the…
No discussion on uniform code for pharmaceutical marketing practices in meeting with PM: IPA
The meeting was called to discuss future road map for growth of the healthcare industry, the IPA said in a statement
Alembic gets US FDA nod for Tizanidine hydrochloride capsules used to treat spasticity
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Zanaflex Capsules, 2 mg, 4 mg, and 6…
Roche aims to ‘underwhelm’ on SMA drug price to challenge rivals
Spinraza's list price is $750,000 in the first year, and $375,000 thereafter, while Novartis's gene therapy for the genetic muscle…